share_log

Does Colgate-Palmolive (NYSE:CL) Deserve A Spot On Your Watchlist?

Does Colgate-Palmolive (NYSE:CL) Deserve A Spot On Your Watchlist?

高露潔(紐交所:CL)值得加入您的自選嗎?
Simply Wall St ·  12/04 02:30

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad.

一些投機者對於能夠扭轉乾坤的公司投資的興奮是巨大的吸引力,所以即使是沒有營業收入、沒有盈利並且一直做不到期望的公司也可以找到投資者。不幸的是,這些高風險的投資往往幾乎沒有可能有所回報,許多投資者會爲此付出代價。虧損的公司可能就像資本的海綿一樣,投資者應該謹慎,以免把好錢投向投機。

In contrast to all that, many investors prefer to focus on companies like Colgate-Palmolive (NYSE:CL), which has not only revenues, but also profits. Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide Colgate-Palmolive with the means to add long-term value to shareholders.

與所有板塊相比,許多投資者更傾向於關注高露潔(紐交所:CL)這樣的公司,它不僅有營業收入,還有利潤。即便這家公司在市場上被合理估值,投資者們也會同意,持續產生穩定的利潤將繼續爲高露潔提供增加長期股東價值的手段。

Colgate-Palmolive's Improving Profits

高露潔利潤不斷改善

Even modest earnings per share growth (EPS) can create meaningful value, when it is sustained reliably from year to year. So it's easy to see why many investors focus in on EPS growth. Outstandingly, Colgate-Palmolive's EPS shot from US$1.91 to US$3.51, over the last year. It's not often a company can achieve year-on-year growth of 84%.

即便是適度的每股收益增長(EPS)也能創造出有意義的價值,只要這種增長能夠從年到年持續。由此可以看出,許多投資者對EPS增長如此關注。值得一提的是,高露潔的EPS在過去一年中從1.91美元飆升至3.51美元。很少有公司能夠實現84%的年增長。

It's often helpful to take a look at earnings before interest and tax (EBIT) margins, as well as revenue growth, to get another take on the quality of the company's growth. Colgate-Palmolive maintained stable EBIT margins over the last year, all while growing revenue 5.1% to US$20b. That's progress.

查看息稅前利潤(EBIT)利潤率以及營業收入增長的情況,往往有助於更好地了解公司的增長質量。高露潔在過去一年中保持了穩定的EBIT利潤率,同時營業收入增長了5.1%,達到了200億美金。這是一個進步。

You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart.

您可以查看下圖中企業的營收和收益增長趨勢。要查看實際數字,請單擊圖表。

big
NYSE:CL Earnings and Revenue History December 3rd 2024
紐交所:高露潔 盈利和營業收入歷史 2024年12月3日

In investing, as in life, the future matters more than the past. So why not check out this free interactive visualization of Colgate-Palmolive's forecast profits?

在投資中,如同生活,未來比過去更重要。那麼爲什麼不查看這個高露潔的免費互動可視化預測利潤呢?

Are Colgate-Palmolive Insiders Aligned With All Shareholders?

高露潔的內部人士與所有板塊股東一致嗎?

Since Colgate-Palmolive has a market capitalisation of US$79b, we wouldn't expect insiders to hold a large percentage of shares. But we are reassured by the fact they have invested in the company. With a whopping US$76m worth of shares as a group, insiders have plenty riding on the company's success. That's certainly enough to let shareholders know that management will be very focussed on long term growth.

由於高露潔的市值爲790億美金,我們不期望內部人士持有大量股份。但我們通過他們投資於公司的事實感到安心。內部人士作爲一個整體持有7600萬美元的股份,顯示他們對公司成功有很大期望。這無疑足以讓股東知道管理層將非常專注於長期增長。

Does Colgate-Palmolive Deserve A Spot On Your Watchlist?

高露潔值得在您的自選中佔有一席之地嗎?

Colgate-Palmolive's earnings have taken off in quite an impressive fashion. That sort of growth is nothing short of eye-catching, and the large investment held by insiders should certainly brighten the view of the company. At times fast EPS growth is a sign the business has reached an inflection point, so there's a potential opportunity to be had here. Based on the sum of its parts, we definitely think its worth watching Colgate-Palmolive very closely. It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Colgate-Palmolive , and understanding these should be part of your investment process.

高露潔的營業收入以相當令人印象深刻的方式增長。這種增長無疑引人注目,內部人士的大量投資肯定會讓人對公司更加樂觀。在某些時候,快速的每股收益增長意味着業務達到了轉折點,這裏確實存在潛在的機會。根據其整體情況,我們認爲需要非常密切關注高露潔。同時仍然需要考慮投資風險始終存在的事實。我們已經識別出高露潔的2個警示信號,理解這些信息應該成爲您投資過程的一部分。

While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in the US with promising growth potential and insider confidence.

儘管不增長收益且沒有內部人士購買的股票可能會有回報,但對於重視這些關鍵指標的投資者來說,以下是在美國具有潛在增長和內部人士信心的經過慎重篩選的公司列表。

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

請注意,本文討論的內部交易是指在相關司法管轄區中報告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論